Clinical Trial

Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease

Name: Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease — clinical trial record (NCT07141810)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Early antifibrotic therapy for f-ILD

Trial Details

NCT Number	NCT07141810
Lead Sponsor	Shanghai Pulmonary Hospital, Shanghai, China
Conditions	Fibrotic Interstitial Lung Disease
Enrollment	104 participants
Start Date	2025-10-01
Primary Completion	2028-04-30 (estimated)
Study Completion	2028-05-30 (estimated)
Updated on ClinicalTrials.gov	2025-08-26